Clinical trials

  • GEMCITABINE HYDROCHLORIDE for Intrahepatic cholangiocarcinoma | Non-metastatic unresectable intrahepatic cholangiocarcinoma
  • Belimumab for Systemic lupus erythematosus
  • FENTANYL for Breakthrough cancer pain | Cancer-related pain
  • ETOPOSIDE for Medulloblastoma (metastatic) | Embryonal central nervous system tumours (including pinealoblastoma, medulloepithelioma, CNS neuroblastoma, ganglioneuroblastoma)
  • Pembrolizumab for Differentiated thyroid carcinoma | Poorly differentiated thyroid carcinoma | Hürthle (Hurtle) cell carcinoma
  • COR-1167 SODIUM for Worsening heart failure
  • TRIPTORELIN for Endometriosis | Adenomyosis
  • PTC:VS-TC for Post-transplant viral reactivation after allogeneic haematopoietic stem cell transplantation|Cytomegalovirus infection (CMV)|Epstein–Barr virus infection (EBV)|Adenovirus infection (ADV)|BK virus infection
  • TOZORAKIMAB for Asthma
  • LIRAGLUTIDE for Knee osteoarthritis | Knee synovitis
  • Bevacizumab for Hepatocellular carcinoma
  • TREOSULFAN for Ewing sarcoma